Eton Pharmaceuticals, Inc.
ETONNext catalyst
LIBERVANT (diazepam buccal film)
Seizure clusters / acute repetitive seizures in patients with epilepsy (label expansion to ages 6 to 11)
Get an email about ETON's next catalysts
Track Eton Pharmaceuticals (ETON) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 3 more upcoming events in our data (PDUFA date).See the timeline
4 upcoming, 1 past
FDA PDUFA Date ET-105 (standard)
For adult refractory gastroesophageal reflux disease (rGERD). NDA filing. Extracted from SEC filing: 8-K
SourceFDA PDUFA Date LIBERVANT (diazepam buccal film)
For Seizure clusters / acute repetitive seizures in patients with epilepsy (label expansion to ages 6 to 11). NDA filing. Extracted from SEC filing: EXHIBIT 99.1 PRESS RELEASE RELATING TO LIBERVANT LICENSING AGREEEMENT
SourceFDA PDUFA Date ASN-001
Extracted from: Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
SourceFDA PDUFA Date KHINDIVI
sNDA accepted. AI-extracted from: Eton Pharmaceuticals Reports Third Quarter 2026 Financial Results
SourceUpcoming FDA decisions
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is Eton Pharmaceuticals, Inc.'s next FDA catalyst?→
Eton Pharmaceuticals, Inc.'s (ETON) next tracked catalyst is a PDUFA date expected Mar 29, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track ETON biotech catalysts?→
Add ETON to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Eton Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.